Home2196 • HKG
add
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
Previous close
$12.64
Day range
$12.42 - $12.86
Year range
$11.32 - $23.20
Market cap
60.92B HKD
Avg Volume
3.96M
P/E ratio
12.94
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Mar 2024info | Y/Y change |
|---|---|---|
Revenue | 10.16B | -6.56% |
Operating expense | — | — |
Net income | 609.73M | -38.22% |
Net profit margin | 6.00 | -33.92% |
Earnings per share | — | — |
EBITDA | 1.64B | 1.81% |
Effective tax rate | 22.80% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Mar 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.02B | -6.45% |
Total assets | 113.75B | 5.93% |
Total liabilities | 56.21B | 7.41% |
Total equity | — | — |
Shares outstanding | 2.67B | — |
Price to book | 0.73 | — |
Return on assets | 2.16% | — |
Return on capital | 2.66% | — |
Cash Flow
Net change in cash
| (CNY) | Mar 2024info | Y/Y change |
|---|---|---|
Net income | 609.73M | -38.22% |
Cash from operations | 917.31M | 5.05% |
Cash from investing | -1.19B | -768.33% |
Cash from financing | 98.64M | -65.02% |
Net change in cash | -151.74M | -115.96% |
Free cash flow | -1.85B | 45.37% |
About
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International.
As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
CEO
Founded
1994
Website
Employees
40,370
